Last edited by Doujar

3 edition of Clinical aspects of the teratogenicity of drugs found in the catalog.

Clinical aspects of the teratogenicity of drugs

Hideo Nishimura

Clinical aspects of the teratogenicity of drugs

by Hideo Nishimura

  • 158 Want to read
  • 14 Currently reading

Published by Excerpta Medica, American Elsevier Pub. Co. in Amsterdam, New York .
Written in English

    Subjects:
  • Fetus -- Effect of drugs on.,
  • Teratogenic agents.,
  • Abnormalities, Human -- Etiology.,
  • Teratogens.,
  • Abnormalities, Drug-induced.

  • Edition Notes

    StatementHideo Nishimura and Takashi Tanimura.
    ContributionsTanimura, Takashi, joint author.
    Classifications
    LC ClassificationsRG627 .N57
    The Physical Object
    Paginationxii, 453 p. :
    Number of Pages453
    ID Numbers
    Open LibraryOL5207843M
    ISBN 100444167048
    LC Control Number75034353

    The articles that appear in Antiviral Drugs - Aspects of Clinical Use and Recent Advances cover several topics that reflect the varied mechanisms of viral disease pathogenesis and treatment. Clinical management and new developments in the treatment of virus-related diseases are the two main sections of the book. The first part reviews the treatment of hepatitis C virus Cited by: 6.   Missing a single dose. Management of a missed dose depends on the length of the delay, drug half life, and bioavailability. As a general rule, a missed dose should be taken within four hours of the prescribed dose (drugs with long half lives or sustained release preparations should be taken within 12 hours), after which patients should take the next dose Author: Maria Christina Petropoulos, Karen Bonaiuto, Janet Currier, Janet Currier, Deb K. Pal, Deb K. Pal.

    Teratogenicity of Drugs Most Commonly Used in Pregnancy. Medications taken to treat coughs and colds, which are primarily available without prescription, are among the most commonly used medicines in pregnancy, but the safety of these products with respect to . Teratology is the study of abnormalities of physiological is often thought of as the study of human congenital abnormalities, but it is broader than that, taking into account other non-birth developmental stages, including puberty; and other organisms, including related term developmental toxicity includes all manifestations of abnormal development that are .

      Books; Specialties. Hematology/Oncology however, hundreds of doctors in the United States had received the drug for use in clinical trials. Teratogenicity is the most severe and well. Antiepileptic Drug Interactions and Teratogenicity that we had not observed any clinical indications that such increased phenytoin metabolism had occurred in any of the thousands of our Author: Samuel Livingston, Irving Pruce, Lydia L Pauli.


Share this book
You might also like
Environmental issues

Environmental issues

Politics in Islam

Politics in Islam

Emancipation of the Russian serfs

Emancipation of the Russian serfs

Restrictions to teachers trade union activities

Restrictions to teachers trade union activities

study on Kamtchatka uredinales

study on Kamtchatka uredinales

Linear models, statistical information, and statistical inference

Linear models, statistical information, and statistical inference

Traffic monitoring review (1980)

Traffic monitoring review (1980)

Dragonflies & damselflies of Cape Cod

Dragonflies & damselflies of Cape Cod

Curtins gift

Curtins gift

Information systems today

Information systems today

foundations of the Australian monetary system, 1788-1851.

foundations of the Australian monetary system, 1788-1851.

Eradication or control of European corn borer.

Eradication or control of European corn borer.

Decriminalisation

Decriminalisation

Treaty Between His Majesty the King and the Slave, Dogrib, Loucheux, Hare and Other Indians of the Territory.

Treaty Between His Majesty the King and the Slave, Dogrib, Loucheux, Hare and Other Indians of the Territory.

Clinical aspects of the teratogenicity of drugs by Hideo Nishimura Download PDF EPUB FB2

Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (K), or click on a page image below to browse page by page. Book Review Clinical Aspects of the Teratogenicity of Drugs Br Med J ; 1 doi: Clinical Aspects of the Teratogenicity of Drugs Br Med J ; BibTeX (win & mac) You are going to email the following Clinical Aspects of the Teratogenicity of Drugs.

Your Personal Message. UK jobs;Author: D H M Woollam. Sorry, our data provider has not provided any external links therefore we are unable to provide a link to the full : D H M Woollam. In its clinical use a drug is intended to have a therapeutic action, but it can also promote toxic reactions and have side effects.

The latter can reflect deficiencies in a drug's selectivity and may even occur at the same time or with smaller doses than those that are therapeutically effective. Purchase Cognitive, Clinical, and Neural Aspects of Drug Addiction - 1st Edition. Print Book & E-Book. ISBNBook Edition: 1.

Teratogenic mechanisms of medical drugs Article Literature Review (PDF Available) in Human Reproduction Update 16(4) January with 2, Reads How we measure 'reads'. Moustafa takes this book one step further by reviewing the psychological and neural causes of relapse including the role of stress, anxiety and depression.

By examining both the causes of drug addiction and relapse, this book will help clinicians create individualized treatment options for patients suffering from drug addiction.

Teratogenic Drugs and Teratogenicity Tests 1. Teratogenicity of Drugs & Teratogenicity Tests 2. Teratogenicity of Drugs 3. • Any substance that can induce or increase the incidence of a congenital malformation • Recognition of human teratogens offers the opportunity to prevent exposure 4.

Effects of Commonly Used Benzodiazepines on the Fetus, the Neonate, and the Nursing Infant. the bulk of clinical experience with this drug worldwide indicates that pregnant women can be treated with chlordiazepoxide without adverse effects on themselves or their infants. Lack of evidence of teratogenicity of benzodiazepine drugs in by: Teratogenic Effects of Drugs is the hardcover version of a computerized database known as the Teratogen Information System (TERIS), the on-line version of which first appeared in This new edition will continue to serve as a reference for use by clinical and research geneticists, teratologists, obstetricians, and pediatricians.5/5(1).

Abstract. The possible teratogenic effect of drugs used in veterinary medicine is important for two main reasons: safety for the target animals and residue risks for the consumers of animal products. The general laws of chemical teratogenesis are: specific sensitivity, smallness of the teratogenic dose, existence of a sensitive period, Cited by: Additional Physical Format: Online version: Nishimura, Hideo, Clinical aspects of the teratogenicity of drugs.

Amsterdam: Excerpta Medica ; New York: American. The detection of the teratogenic effect of drugs remains a challenge. The sudden appearance of the problem has baffled pharmacologists.

The testing of the teratogenic action of a new drttg requires a systematic and complete investigation, without bias, based on the chemical s1rttctttre or pharmacologic by: Mario Manto, Gaetano Perrotta, in Handbook of Clinical Neurology, Phenytoin.

Teratogenicity manifesting as a small brain with neocerebellar hypoplasia has been reported in an infant with dysmorphic features (Squier et al., ). The case was born to an epileptic mother who had taken phenytoin and valproate during pregnancy.

Panel's Recommendations Regarding Teratogenicity; Panel's Recommendations All cases of antiretroviral (ARV) drug exposure during pregnancy should be reported to the Antiretroviral Pregnancy Registry (AIII).; Based on multiple studies indicating no difference in rates of total birth defects for first-trimester exposure compared with later ARV drug exposures.

Retinoids are valuable drugs in the dermatologic armamentarium, being employed in daily clinical practice. The text provides an in-depth update on the latest thinking on pharmacology, clinical use, side effects, and follow-up of retinoid therapy in dermatology; it also addresses topics related to retinoid use in special circumstances, such as vulnerable Author: Ayse Serap Karadag, Berna Aksoy, Lawrence Charles Parish.

“Book presents the science behind what truly is an allergic reaction to guide evidence-based decisions on drug therapy. It addresses the clinical aspects of allergy in addition to the mechanism of disease, the molecular chemistry behind allergy, and other key by: The second volume, Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, is devoted to the clinical aspects of drug resistance.

Although there is evidence that restricted use of a specific antibiotic can be followed by a decrease in drug resistance to that agent, drug resistance control is not easily achieved.

The groups of infants exposed to either one anticonvulsant drug or two or more drugs had a higher frequency of all of the features of the embryopathy associated with exposure to anticonvulsants (i Cited by: insufficient human data on the use of Descovy during pregnancy to inform a drug -associated risk of birth defects and miscarriage.

Tenofovir alafenamide (TAF) use in women during pregnancy has not been evaluated; however, emtricitabine (FTC) use during pregnancy has been evaluated in a limited number of women.

reported to the Size: 1MB. “The current book offers valuable knowledge regarding mechanisms, clinical aspects, diagnostic methods, and therapeutic approach in drug allergy, which will aid the caring physician to successfully diagnose and manage affected individuals. The summary points at the end of each chapter represent an outstanding feature of this book.Teratogenicity of antiepileptic drugs: State of the art Article Literature Review in Current Opinion in Neurology 18(2) May with 30 Reads How we measure 'reads'.U.S.

Food and Drug Administration New Hampshire Avenue Silver Spring, MD INFO-FDA () Contact FDA.